A federal investigation into Jim Irsay’s death raises questions about medical oversight and addiction treatment in America.
Story Highlights
- The FBI is investigating the death of Jim Irsay, focusing on his doctor’s prescription practices.
- Irsay, former owner of the Indianapolis Colts, had a known history of substance abuse.
- Dr. Haroutunian prescribed opioids and ketamine to Irsay before his death.
- The case draws parallels to the Matthew Perry investigation regarding controlled substances.
FBI Investigation into Irsay’s Death
In January 2026, the FBI launched an investigation into the May 2025 death of Jim Irsay, the owner of the Indianapolis Colts. The investigation focuses on the prescription practices of Dr. Harry Haroutunian, a California addiction specialist. Authorities are examining whether the use of opioids and ketamine, prescribed by Dr. Haroutunian, contributed to Irsay’s death.
This case is reminiscent of the investigation into actor Matthew Perry’s death, where inappropriate ketamine use was scrutinized.
Irsay, who publicly admitted to battling addiction, died of cardiac arrest at age 65. Reports suggest he relapsed in the last years of his life, with substantial quantities of controlled substances prescribed to him. The FBI, with a grand jury subpoena, is gathering records and testimonies related to Irsay’s substance use and his interactions with Dr. Haroutunian.
Implications for the Colts and Addiction Treatment
The Indianapolis Colts organization has acknowledged the investigation but stated they haven’t been contacted by the FBI yet. Irsay’s daughters, who now own the team, are managing the franchise amidst this scrutiny.
The investigation could impact how addiction treatment is regulated, particularly concerning opioids and ketamine. This case might establish new precedents for physician liability in addiction contexts, echoing the Perry case’s outcomes.
The FBI is investigating the death of former Colts owner Jim Irsay
The same doctor accused of supplying him with massive amounts of opioids and ketamine also signed the death certificate and ruled it a “natural” death per @washingtonpost pic.twitter.com/Eb9R8d4ekt
— Bussin' With The Boys (@BussinWTB) January 22, 2026
Dr. Haroutunian has not commented on the allegations, but his medical practices are under severe scrutiny. The case underscores the potential consequences of prescribing controlled substances outside traditional medical protocols, with federal authorities actively monitoring such practices.
Broader Industry Effects
The ongoing investigation into Irsay’s death is likely to influence federal oversight of controlled substances in addiction treatment. It highlights the need for stringent regulations and guidelines to prevent misuse.
As the investigation unfolds, it could lead to stricter controls on how addiction specialists prescribe medications like ketamine, ensuring patient safety and adherence to established medical standards.
Death of Indianapolis Colts owner Jim Irsay under federal investigation: Sources https://t.co/AcAsEZhKHp
— Action News on 6abc (@6abc) January 24, 2026
As federal agencies continue their inquiry, the case remains in preliminary stages, with no charges filed yet. The developments in this investigation could have lasting impacts on the medical community and addiction treatment practices, emphasizing the importance of ethical medical conduct.
Sources:
ESPN: Colts say FBI launched probe into death of former owner Jim Irsay
ABC News: Death of Indianapolis Colts owner Jim Irsay under federal investigation
